Table 1.
Characteristics | N (%) |
---|---|
Sex | |
Male | 79 (73.1) |
Female | 29 (26.9) |
Age | |
Median (year) | 60 (36–90) |
<70 | 69 |
>70 | 39 |
Tumor site | |
upper-mid | 77 (71.2) |
low | 31 (28.7) |
Clinical stage at diagnosis | |
T Stage | |
T2–3 | 44 (61.1) |
T4 | 42 (38.9) |
N Stage | |
N0–1 | 62 (57.4) |
N2 | 46 (42.6) |
Adjuvant chemotherapy | |
None | 12 (11) |
5-FU monotherapy | 41 (38) |
5-FU + oxalipaltin | 55 (51) |
5-FU, 5-fluorouracil.